Institut des Sciences Chimiques de Rennes (ISCR), UMR CNRS 6226, groupe COrInt, Université de Rennes 1 (UR1), Campus de Beaulieu, Bât. 10A, 263 Avenue du Général Leclerc, CS 74205, 35042, Rennes Cedex, France.
Laboratoire de Chimie Bio Organique et Substances Naturelles (LCBOSN), Université Nangui Abrogoua (UNA), 02 BP 801, Abidjan, Côte d'Ivoire.
Mol Divers. 2018 Aug;22(3):685-708. doi: 10.1007/s11030-018-9824-5. Epub 2018 Apr 5.
A series of 16 new ethyl [Formula: see text]-amino benzimidazole acrylate derivatives 12(a-p) with a (2E)-s-cis/trans conformation and bearing two points of diversity was designed and synthesized by using a multi-step strategy (reductive amination, deprotection in acidic media and transamination) in moderate to good yields from ethyl 3-dimethylamino-2-(1H-benzimidazol-2-yl)acrylate (5) and monosubstituted N-Boc diamines (7a,7b) as starting building blocks. Products 12 were evaluated for their in vitro cytotoxic potential against six selected human cell lines (Huh7-D12, Caco2, MDA-MB231, HCT116, PC3 and NCI-H727). Compounds 12a, 12e and 12l exhibited selective and micromolar antitumor activities against Huh7-D12 and Caco2 cell lines.
设计并合成了一系列新的 16 个乙基[式:见文本]-氨基苯并咪唑丙烯酸酯衍生物 12(a-p),这些衍生物具有(2E)-s-顺/反构象,并带有两个多样性点,通过多步策略(还原胺化、酸性介质中脱保护和转氨基),以中等至良好的收率从乙基 3-二甲基氨基-2-(1H-苯并咪唑-2-基)丙烯酸酯(5)和单取代 N-Boc 二胺(7a、7b)作为起始构建块合成。评估了产物 12 对六种选定的人类细胞系(Huh7-D12、Caco2、MDA-MB231、HCT116、PC3 和 NCI-H727)的体外细胞毒性潜力。化合物 12a、12e 和 12l 对 Huh7-D12 和 Caco2 细胞系表现出选择性和微摩尔抗肿瘤活性。